SCHEMBL3145246

SCHEMBL3145246

NC(=O)c1nnccc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K3 P46734 3/20 0.44
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
LCK P06239 1/20 0.39
MAP2K6 P52564 1/20 0.39
BTK Q06187 1/20 0.39
MAP3K19 Q56UN5 1/20 0.39
NEK10 Q6ZWH5 1/20 0.39
PDPK1 O15530 2/20 0.38
ILK Q13418 1/20 0.35
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
IKBKB O14920 5/20 0.33
P2RX7 Q99572 1/20 0.33
LRRK2 Q5S007 1/20 0.33
CDC7 O00311 1/20 0.33
DBF4 Q9UBU7 1/20 0.33
F7 P08709 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30591940 1.00 MAP2K3 (0.44) MAP2K3MEN1KMT2ALCKMAP2K6
SCHEMBL5120006 0.83 KDM4E (0.44) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL19691158 0.78 KMT2A (0.37) MAP2K3MEN1KMT2ALCKMAP2K6
SCHEMBL28309038 0.78 SIRT3 (0.38) MAP2K3MEN1KMT2ALCKMAP2K6
SCHEMBL1403852 0.77 SIRT3 (0.46) MAP2K3MEN1KMT2ALCKMAP2K6
SCHEMBL7022252 0.75 MEN1 (0.35) MAP2K3MEN1KMT2ALCKMAP2K6
SCHEMBL7020095 0.75 MEN1 (0.35) MAP2K3MEN1KMT2ALCKMAP2K6
SCHEMBL29031476 0.75 MAPT (0.47) MEN1KMT2AALDH1A1HSD17B10SMN1; SMN2
SCHEMBL22290178 0.74 P2RX7 (0.34) MAP2K3MEN1KMT2ALCKMAP2K6
SCHEMBL19249750 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115996911-A Substituted N-phenylacetamides having P2X4 receptor antagonistic activity 拜耳公司 2023-04-21 CN disclosed
CN-115989218-A Use of N-phenylacetamides having P2X4 receptor antagonistic activity for the treatment of certain eye diseases 拜耳公司 2023-04-18 CN disclosed
WO-2010034500-A1 SUBSTITUTED IMIDAZOPYRIDINE, IMIDAZOPYRAZINE, IMIDAZOPYRIDAZINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR ANTAGONISTS SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2010-04-01 WO disclosed
EP-2168965-A1 Substituted imidazopyridine, imidazopyrazine, imidazopyridazine and imidazopyrimidine derivatives as melanocortin-4 receptor antagonists Santhera Pharmaceuticals (Schweiz) AG (CH) 2010-03-31 EP disclosed